# The LINFU® U.S. Registry for the in the General Population Without Risk Factors

> **NCT06276803** · — · NOT_YET_RECRUITING · sponsor: **Adenocyte, LLC** · enrollment: 500 (estimated)

## Conditions studied

- Pancreatic Cancer
- Pancreatic Ductal Adenocarcinoma
- Pancreatic Dysplasia

## Interventions

- **DIAGNOSTIC_TEST:** LINFU®

## Key facts

- **NCT ID:** NCT06276803
- **Lead sponsor:** Adenocyte, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-09-15
- **Primary completion:** 2034-09-15
- **Final completion:** 2034-12-15
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2024-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06276803

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06276803, "The LINFU® U.S. Registry for the in the General Population Without Risk Factors". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06276803. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*